BBNX logo

Beta Bionics, Inc. (BBNX) Cash and Cash Equivalents

Annual Cash & Cash Equivalents:

$30.43M+$3.87M(+14.55%)
December 31, 2024

Summary

  • As of today, BBNX annual cash & cash equivalents is $30.43 million, with the most recent change of +$3.87 million (+14.55%) on December 31, 2024.
  • During the last 3 years, BBNX annual cash & cash equivalents has risen by +$2.76 million (+9.96%).
  • BBNX annual cash & cash equivalents is now at all-time high.

Performance

BBNX Cash and Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBNXbalance sheet metrics

Quarterly Cash & Cash Equivalents:

$228.69M-$21.03M(-8.42%)
September 30, 2025

Summary

  • As of today, BBNX quarterly cash & cash equivalents is $228.69 million, with the most recent change of -$21.03 million (-8.42%) on September 30, 2025.
  • Over the past year, BBNX quarterly cash & cash equivalents has increased by +$167.79 million (+275.53%).
  • BBNX quarterly cash & cash equivalents is now -8.42% below its all-time high of $249.72 million, reached on June 30, 2025.

Performance

BBNX Quarterly Cash & Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBNXbalance sheet metrics

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

BBNX Cash and Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+14.6%+275.5%
3Y3 Years+10.0%-
5Y5 Years+10.0%-

BBNX Cash and Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+14.6%-8.4%+275.5%
5Y5-Yearat high+14.6%-8.4%+275.5%
All-TimeAll-Timeat high+14.6%-8.4%+275.5%

BBNX Cash and Cash Equivalents History

DateAnnualQuarterly
Sep 2025
-
$228.69M(-8.4%)
Jun 2025
-
$249.72M(+7.9%)
Mar 2025
-
$231.47M(+123.5%)
DateAnnualQuarterly
Dec 2024
$30.43M(+14.6%)
$103.58M(+70.1%)
Sep 2024
-
$60.90M(-37.1%)
Dec 2023
$26.57M(-4.0%)
$96.75M
Dec 2022
$27.68M
-

FAQ

  • What is Beta Bionics, Inc. annual cash & cash equivalents?
  • What is the all-time high annual cash & cash equivalents for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. annual cash & cash equivalents year-on-year change?
  • What is Beta Bionics, Inc. quarterly cash & cash equivalents?
  • What is the all-time high quarterly cash & cash equivalents for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. quarterly cash & cash equivalents year-on-year change?

What is Beta Bionics, Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of BBNX is $30.43M

What is the all-time high annual cash & cash equivalents for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high annual cash & cash equivalents is $30.43M

What is Beta Bionics, Inc. annual cash & cash equivalents year-on-year change?

Over the past year, BBNX annual cash & cash equivalents has changed by +$3.87M (+14.55%)

What is Beta Bionics, Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of BBNX is $228.69M

What is the all-time high quarterly cash & cash equivalents for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high quarterly cash & cash equivalents is $249.72M

What is Beta Bionics, Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, BBNX quarterly cash & cash equivalents has changed by +$167.79M (+275.53%)
On this page